Your browser doesn't support javascript.
loading
Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study.
Hofman, Zonne L M; Clark, Chantal C; Hack, C Erik; de Maat, Steven; Maas, Coen.
  • Hofman ZLM; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands; Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Clark CC; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hack CE; Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • de Maat S; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Maas C; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: cmaas4@umcutrecht.nl.
J Allergy Clin Immunol ; 146(6): 1446-1449.e5, 2020 12.
Article en En | MEDLINE | ID: mdl-32360287
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Bradiquinina / Calicreínas / Inhibidores de Serina Proteinasa / Angioedemas Hereditarios Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Bradiquinina / Calicreínas / Inhibidores de Serina Proteinasa / Angioedemas Hereditarios Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article